Average Co-Inventor Count = 8.73
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (35 from 3,685 patents)
2. Five Prime Therapeutics, Inc. (4 from 72 patents)
3. Bristol Meyers Squibb Company (1 from 41 patents)
36 patents:
1. 12419953 - Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies
2. 12409223 - Antagonistic CD40 monoclonal antibodies and uses thereof
3. 12195535 - Antibodies binding to VISTA at acidic pH
4. 12173069 - Antibodies binding to vista at acidic pH
5. 12091462 - Antibodies binding to vista at acidic pH
6. 12077584 - Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)
7. 12065505 - Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof
8. 11981734 - Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
9. 11926673 - Antagonistic CD40 monoclonal antibodies and uses thereof
10. 11858979 - Fibronectin based scaffold domain proteins that bind PCSK9
11. 11813315 - Fibronectin based scaffold domain proteins that bind to myostatin
12. 11795231 - Antagonistic CD40 monoclonal antibodies and uses thereof
13. 11773178 - Antagonistic CD40 monoclonal antibodies and uses thereof
14. 11708405 - IP-10 antibodies and their uses
15. 11603406 - Antibodies binding to VISTA at acidic pH